Transcatheter Mitral Valve Repair for Inotrope Dependent Cardiogenic Shock

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 144 participants.

Also called NCT05298124

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 144 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05298124
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Canada (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05298124. Randomized; no masking; primary purpose treatment. Start 2022-05-26 (actual); primary completion 2028-05 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Transcatheter Mitral Valve Repair for Inotrope Dependent Cardiogenic Shock
Acronym
MINOS
Condition
Cardiogenic Shock
Condition
Mitral Regurgitation
Intervention (Device)
Transcatheter edge-to-edge repair
Intervention (Other)
Medical therapy
Lead sponsor
Ottawa Heart Institute Research Corporation (class: other)

Record details

Record id
cardio:ct-nct05298124
Content hash
7b29b1aa48786d09048a01d11a0e1c94bdf09dba3eef871d2899485faeb0f8fb